Prescription drug · NDA
Procardia XL (nifedipine) NDC 0069-2650
Nifedipine 30 mg/1 · Tablet, Film coated, Extended release · Oral · Pfizer Laboratories Div Pfizer Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0069-2650-41 | 00069265041 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (0069-2650-41)Marketed from Sep 6, 1989 | |
| 0069-2650-66 | 00069265066 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-2650-66)Marketed from Sep 6, 1989 | |
| 0069-2650-72 | 00069265072 | 300 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-2650-72)Marketed from Sep 6, 1989 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Procardia XLSuffix: XL
- Generic name (nonproprietary)
- nifedipine
- Active ingredients
- Nifedipine — 30 mg/1
- Dosage form
- Tablet, Film coated, Extended release
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 019684
- Marketing start
- Listing expires
- Other FDA classes
- Calcium Channel Antagonists (Mechanism)Dihydropyridines (Chemical structure)
- Identifiers
- Product ID 0069-2650_c24a0478-46d4-413a-8d48-c21af0bc10e4SPL ID c24a0478-46d4-413a-8d48-c21af0bc10e4SPL set ID 8ebcb33c-f43b-4b36-9f94-9774b2a59e06RxCUI 207772, 207773, 207774, 1812011, 1812013, 1812015UNII I9ZF7L6G2L
- Pharmacologic class
- Dihydropyridine Calcium Channel Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400069265041followed by a unit qualifier and the quantityPackage 00069-2650-41. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE I. Vasospastic Angina PROCARDIA XL is indicated for the management of vasospastic angina confirmed by any of the following criteria: 1) classical pattern of angina at rest accompanied by ST segment elevation, 2) angina or coronary artery spasm provoked by ergonovine, or 3) angiographically demonstrated coronary artery spasm. In those patients who have had angiography, the presence of significant fixed obstructive disease is not incompatible with the diagnosis of vasospastic angina, provided that the above criteria are satisfied. PROCARDIA XL may also be used where the clinical presentation suggests a possible vasospastic component, but where vasospasm has not been confi…
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 019684
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Procardia XLnifedipine | Nifedipine 60 mg/1 | Tablet, Film coated, Extended releaseOral | Pfizer Laboratories Div Pfizer Inc | 0069-2660 |